Catheter Related Bloodstream Infection Market to Grow at CAGR of 5.63% through 2031
Rising healthcare costs and economic burden of infections are expected to drive the Global Catheter-Related Bloodstream Infection Market growth in the forecast period, 2027-2031.
According to
TechSci Research report, “Catheter Related Bloodstream Infection Market – Global
Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2021-2031F”, the Global Catheter Related Bloodstream Infection Market will grow from USD 1.62 Billion in 2025 to USD 2.25 Billion by 2031 at a 5.63% CAGR.
The Global Catheter-Related Bloodstream Infection Market is currently experiencing substantial growth, driven by increased patient numbers undergoing catheterisation procedures, rising awareness of infection prevention, and advances in medical technologies aimed at reducing the incidence of catheter-related bloodstream infections (CRBSIs). As the prevalence of chronic
diseases, such as kidney failure, cancer, and diabetes, continues to rise
globally, more patients require invasive medical procedures that involve the
use of central venous catheters, hemodialysis catheters, and other types of
vascular access devices. This growing demand for catheter-based interventions
has contributed to the rising risk of CRBSIs, a significant complication that can
lead to increased morbidity, mortality, and extended hospital stays.
The healthcare
industry's emphasis on improving patient safety and infection control is also
fueling market growth. Healthcare-associated infections (HAIs), including
CRBSIs, remain a significant concern for hospitals worldwide, leading to the
implementation of stringent infection prevention protocols. Hospitals and
healthcare providers are increasingly adopting guidelines for catheter care, including proper insertion techniques, routine monitoring, and the use of antimicrobial-coated catheters, to reduce the risk of infection. These
guidelines, coupled with advances in medical technology, are helping to reduce
the incidence of CRBSIs, but also driving the demand for specialized
treatments, diagnostics, and infection prevention products.
A key factor
driving the market is the increasing adoption of antimicrobial agents for the treatment and prevention of CRBSIs. Broad-spectrum antibiotics,
antifungal agents, and antiseptic solutions are widely used to manage
infections in patients with central venous catheters or other types of vascular
access devices. Antimicrobial lock therapies have become increasingly popular
in the management of CRBSIs, particularly in high-risk patients who require
long-term catheterization. These therapies involve infusing a concentrated
antibiotic solution into the catheter lumen to prevent pathogen growth and biofilm formation, which are major causes of persistent
infections. The use of advanced infection-control measures has become critical for reducing CRBSIs, thereby increasing demand for innovative
therapies and products.
The global
market for catheter-related bloodstream infections is also being shaped by a
growing focus on improving diagnostic capabilities. Early detection of
infections is crucial for preventing the progression of CRBSIs and ensuring
prompt treatment. Diagnostic tools such as blood culture tests, molecular
assays, and biofilm detection technologies are becoming more sophisticated,
allowing healthcare providers to identify infections more accurately and
efficiently. This has led to increased use of rapid diagnostic tests in hospital settings, contributing to market growth. Advancements in
diagnostic technologies are helping healthcare professionals make more informed
decisions about treatment options, thereby improving patient outcomes.
The market is
also benefiting from the increasing awareness of CRBSIs and the need for
preventive measures. Education and awareness campaigns for healthcare professionals and patients play a significant role in promoting
best practices for catheter care and infection prevention. These campaigns have
led to greater adoption of infection control measures, including the use of
antimicrobial dressings, proper hand hygiene, and sterile insertion techniques,
all of which help reduce the risk of CRBSIs. As more healthcare providers and
patients become aware of the importance of preventing catheter-related
infections, the demand for effective prevention products and services continues
to rise.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Catheter Related Bloodstream Infection Market”
The Global Catheter
Related Bloodstream Infection Market is segmented into treatment type, source
of infection, distribution channel, regional distribution, and company.
Based on the Treatment Type, antimicrobial agents are currently the fastest-growing segment in the global catheter-related bloodstream infection (CRBSI) market. This growth is driven by their broad applicability, efficacy in combating a range of pathogens, and their essential role in both the prevention and treatment of CRBSIs. Anti-microbial agents, including antibiotics, antifungals, and antiseptics, have become increasingly vital as healthcare providers continue to focus on improving patient outcomes by preventing and managing infections more effectively.
The rising global incidence of catheter-related bloodstream infections, especially in high-risk patient populations such as those undergoing long-term catheterization or individuals with weakened immune systems, has resulted in an increased demand for these agents. Additionally, the growing prevalence of multidrug-resistant organisms (MDROs) and the need for more effective infection-control measures are expected to drive continued growth in antimicrobial use. Their versatility, including antimicrobial-coated catheters and systemic treatments, makes them indispensable tools in modern healthcare settings. Furthermore, ongoing advances in antimicrobial technology, along with increasing research and development in targeted therapies, are expected to drive the rapid expansion of this segment. The push for preventive treatments in high-risk settings, coupled with greater awareness of the importance of infection control, will continue to make antimicrobial agents the fastest-growing segment of the CRBSI market.
Based on region,
Europe is the second-dominating region in the Global Catheter Related
Bloodstream Infection Market. Europe benefits from a robust healthcare
infrastructure, widespread access to advanced medical technologies, and
well-established infection control protocols, all of which contribute to the
region's significant role in the market. The increasing prevalence of chronic
diseases, such as kidney failure, diabetes, and cancer, alongside the growing
number of patients requiring long-term catheterization, has led to a higher
incidence of catheter-related bloodstream infections (CRBSIs) in Europe. As a
result, the demand for effective infection prevention, treatment, and
diagnostic solutions has surged, making Europe a key player in the CRBSI
market.
One of the
primary factors driving Europe's market position is the region’s advanced healthcare systems, which are equipped with state-of-the-art diagnostic tools, treatments, and infection-control measures. Hospitals and
healthcare facilities in countries such as Germany, the United Kingdom, France, and Italy are well equipped to manage complex cases of CRBSIs. These healthcare
providers have adopted stringent infection-control protocols and guidelines aimed at reducing the incidence of catheter-related infections. Such
measures include the use of antimicrobial-coated catheters, proper catheter
care procedures, and the widespread implementation of antibiotic stewardship
programs. These initiatives have played a key role in preventing and treating
CRBSIs, thereby increasing demand for related medical products and
services in the region.
Major companies
operating in Global Catheter Related Bloodstream Infection Market
are:
- Teva Pharmaceutical Industries Ltd.
- SteriMax Inc.
- Sanofi S.A.
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- GSK plc
- Fresenius SE & Co. KGaA
- Eli Lilly and Company
- Aurobindo Pharma Limited
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the Global Catheter Related Bloodstream Infection Market looks promising,
driven by ongoing advancements in medical technologies, heightened awareness of
infection prevention, and an increasing demand for specialized treatments. As
healthcare systems worldwide continue to prioritize patient safety, the market
is expected to see significant growth in the adoption of antimicrobial-coated
catheters, advanced diagnostic tools, and innovative therapies like
antimicrobial lock therapy. The rising prevalence of chronic diseases,
particularly among aging populations, will further elevate the need for
long-term catheterization, increasing the risk of CRBSIs. With a focus on
improving infection control protocols and expanding access to treatment
options, the market is poised for continued expansion, driven by both
technological innovation and a greater emphasis on patient outcomes”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Catheter Related Bloodstream Infection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Anti-microbial Agents and Antibiotic Lock Therapy), By Source of Infection (Coagulase-negative Staphylococcus, S. Aureus, Enteric Gram-negative Bacilli, Yeasts, Enterococci & Streptococci, Pseudomonas, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region and Competition, 2021-2031F”, has evaluated
the future growth potential of Global Catheter Related Bloodstream Infection
Market and provides statistics & information on market size, structure and
future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Catheter Related
Bloodstream Infection Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com